Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
31,601,829
-
Shares change
-
+10,833,752
-
Total reported value, excl. options
-
$299,901,220
-
Value change
-
+$126,057,321
-
Put/Call ratio
-
1.01%
-
Number of buys
-
92
-
Number of sells
-
-29
-
Price
-
$9.49
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2018
138 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2018.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,601,829 shares
of 113,177,462 outstanding shares and own 27.92% of the company stock.
Largest 10 shareholders include venBio Select Advisor LLC (4,471,300 shares), BOXER CAPITAL, LLC (3,750,000 shares), BlackRock Inc. (2,938,645 shares), VANGUARD GROUP INC (2,369,190 shares), JANUS HENDERSON GROUP PLC (2,060,286 shares), ArrowMark Colorado Holdings LLC (1,723,982 shares), Opaleye Management Inc. (1,200,000 shares), SPHERA FUNDS MANAGEMENT LTD. (782,424 shares), ACUTA CAPITAL PARTNERS, LLC (750,000 shares), and MILLENNIUM MANAGEMENT LLC (740,604 shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.